Panadol Extra

Quick links to important sections

Panadol Extra

Selected form

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Panadol Extra

Property Description
Active Ingredients Acetaminophen (Paracetamol), Caffeine
Form Oral Solid Preparation (Tablet)
Pharmacological Class Non-opioid Analgesic and Adjuvant Combination
Common Use Enhanced Symptomatic Relief
Origin Synthetic Pharmaceutical Compounds

What Kind of Medicine is Panadol Extra and Its Classification?

Panadol Extra is a globally recognized, synthetic, fixed-dose combination medicine classified as an analgesic combination. This Over-The-Counter (OTC) medicine is supplied as an oral solid preparation (tablet). Its identity is defined by the strategic pairing of two active compounds: the established pain reliever Acetaminophen (Paracetamol) and the mild Central Nervous System (CNS) stimulant Caffeine.

This specific formulation is positioned for the adult population and represents a specific therapeutic strategy. The designation as a fixed-dose combination product confirms that the precise amounts of both active substances are integrated into every dose, ensuring consistent delivery for the user, distinguishing it from single-entity preparations.

The Core Components: Acetaminophen and Caffeine

The fundamental composition includes Acetaminophen (Paracetamol), which is clinically recognized for its analgesic and antipyretic properties, and Caffeine, a methylxanthine derivative.

The inclusion of Caffeine serves as a pharmacological adjuvant. This practice is based on its ability to enhance the efficacy of the primary pain reliever. The addition of Caffeine to Acetaminophen is intended to provide enhanced pain relief compared to Acetaminophen alone, establishing the formulation as an option for general discomfort.

General Purpose and Dual-Action Benefit

The overarching purpose of Panadol Extra is to deliver enhanced symptomatic relief through its specific dual-action benefit. This approach results in analgesic potentiation, where the therapeutic effect is greater than the sum of the individual components. A typical use scenario involves relief from general, everyday aches and pains, utilizing the stimulant component to achieve a stronger overall outcome for the user.

What side effects are possible with Panadol Extra?

Possible Side Effects and Safety Information

The safety profile for this fixed-dose combination, containing Acetaminophen (Paracetamol) and Caffeine, is structured around adverse reactions documented in official regulatory sources, organized by System-Organ Class (SOC) and frequency.

Adverse Reaction Classification

Side effects are officially classified into frequency categories. Those related to the stimulant component, Caffeine, such as insomnia, nervousness, anxiety, and palpitations, are often listed as Common or Not Known (frequency cannot be estimated from available data). More severe events, including blood disorders (e.g., thrombocytopenia) and certain hypersensitivity reactions, are generally classified as Very Rare.

SOC Categories: Documented adverse reactions affect key systems, including Hepatobiliary disorders (liver), Nervous system disorders, Immune system disorders, and Blood and lymphatic system disorders.

Serious Adverse Reactions and Safety Constraints

The most critical constraint defined in official labeling is the dose-dependent risk of hepatotoxicity (severe liver damage) linked to the Acetaminophen component. This is the primary reason for the regulatory restriction against using this medication with any other product containing Acetaminophen.

Serious Adverse Reactions officially listed include Anaphylaxis (a severe allergic response) and Severe Cutaneous Adverse Reactions (SCARs), such as Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN). These are rare but medically significant events.

Population-Specific Safety: Caution is mandated for use in individuals with pre-existing conditions, particularly severe hepatic impairment (where use is often contraindicated) and renal impairment. The safety profile notes that prolonged, frequent use may also lead to the development of Medication Overuse Headache.

Overdose and Emergency Response

Overdose of this medicine poses a severe, potentially life-threatening risk, primarily due to the delayed hepatotoxicity associated with the Acetaminophen component. Regulatory documents mandate that individuals must seek immediate medical attention and evaluation following any suspected overdose, even if no initial symptoms are present.

Initial clinical manifestations may include non-specific signs such as anorexia, nausea, vomiting, abdominal pain, and diaphoresis. Over time, this can progress to severe outcomes including hepatic necrosis, hepatic failure, and hepatic encephalopathy, as documented in official labeling. The Caffeine component can contribute to symptoms like tachycardia, arrhythmias, and tremor, and may potentially lead to convulsions in severe scenarios.

Management of overdose is officially required to be initiated immediately and involves determination of plasma paracetamol concentration to guide treatment. N-acetylcysteine (NAC) administration is documented as the specific antidote for Acetaminophen toxicity. Monitoring and supportive measures are crucial, especially for populations noted to be at increased risk, such as those with pre-existing hepatic impairment or a history of chronic alcohol consumption. Urgent, mandatory evaluation and hospitalization are necessary to observe for delayed manifestations and implement life-saving interventions.

Therapeutic Uses of Panadol Extra

What Panadol Extra treats: Main Uses and Benefits

The combination formulation is applied across therapeutic domains involving symptoms related to physical discomfort and acute or disruptive episodes. Applicable within clinical settings that involve acute or disruptive symptom patterns, the medication is commonly used for managing mild to moderate pain and is relevant for easing fever. It is used across domains where additional symptomatic support is needed, and plays a role in managing systemic and localized discomforts.

The medication is commonly used to help with a brief listing of symptoms, including muscular aches, backache, headaches (including tension and migraine discomfort), toothache, and menstrual pain (dysmenorrhoea). It also assists with addressing malaise and sore throat associated with feverish colds. This provides supportive relief when symptoms interfere with routine activities.

“The combination is applied in scenarios where additional management of discomfort is required, and helps patients cope more steadily with symptom fluctuations.”

Quick Fact: Symptomatic Relief for Pain and Fever

The product is used for the relief of symptoms that create noticeable physiological strain, providing supportive relief that helps improve day-to-day comfort during symptomatic periods.

Regulatory References

  1. NIH DailyMed Drug Label Information

Eligibility and Restrictions for Use

Who Can and Cannot Use Panadol Extra?

The population eligibility for Panadol Extra (Paracetamol/Caffeine) is defined by official regulatory documentation, establishing specific restrictions and prohibitions based on age, existing medical conditions, and physiological status.


Eligibility Scope

Classification Population Group Regulatory Status
Permitted Use Adults and Adolescents (aged 12 years and over) Standard labeled condition
Not Recommended Children under 12 years Use not established/Insufficient data
Individuals who are Pregnant or Breastfeeding Not Recommended

Restrictions and Contraindications

Use is absolutely contraindicated for patients with a known history of hypersensitivity to Paracetamol or Caffeine, or for individuals concurrently taking any other medicine that contains Paracetamol.

Restricted or Conditional Use is mandated for individuals with pre-existing organ function compromise, including hepatic impairment (liver disease) or renal impairment (kidney disease). Use is also restricted in physiological states that deplete glutathione levels, such as severe malnutrition or chronic heavy alcohol consumption, due to the increased risk associated with the Paracetamol component. Official guidance states that use in these populations must only occur under specific medical direction.

What should I know about interactions with other medicines?

Official Interaction Restrictions

The interaction profile for this combination medicine, containing Acetaminophen and Caffeine, is governed by specific pharmacokinetic (PK) and pharmacodynamic (PD) restrictions documented in government labeling.

Contraindications and Prohibitions: Co-administration with any other product containing Paracetamol is strictly restricted due to the significant risk of accidental overdose and potential for fatal liver damage. Co-use with Lithium is also not recommended, as the Caffeine component is documented to increase the elimination of Lithium from the body.

Exposure Modification and Metabolic Risk

  • The absorption rate of Acetaminophen is increased by prokinetic agents such as Metoclopramide and Domperidone. Conversely, the absorption is decreased by the anion-exchange resin Cholestyramine.
  • This latter interaction mandates a timing separation rule: Cholestyramine must be administered at least one hour after the Paracetamol dose to minimize reduced exposure.
  • Concomitant use with medicines that induce hepatic enzymes (e.g., Carbamazepine, Phenytoin) increases the risk of Paracetamol toxicity due to enhanced formation of the toxic metabolite.

Pharmacodynamic and Substance Interactions

  • Prolonged, regular daily use may enhance the anticoagulant effect of Warfarin and other coumarin derivatives, increasing the risk of bleeding.
  • The combination with excessive dietary caffeine (e.g., large amounts of coffee) should be restricted due to the potential for additive stimulant-related effects, such as insomnia or restlessness.
  • Chronic consumption of alcohol is identified as a risk factor for Paracetamol-related hepatotoxicity, particularly in populations with glutathione depletion.

Mechanism of Action

PGE2 Modulation within the Central Nervous System (CNS)

The primary component, paracetamol (acetaminophen), acts largely within the central nervous system, a key mechanistic domain. Its action involves modulating pathways that synthesize prostaglandins ( PGE2), which are specific signaling mediators. By influencing these molecular steps, the drug helps dampen excessive signaling involved in the transmission of input relevant to nociception and the elevation of body temperature, influencing systemic responses relevant to nociception and thermoregulation.

Adenosine Receptor Interference for Mechanistic Modulation

The secondary component, caffeine, modulates activity by engaging pathways via interference with adenosine receptors ( A1 and A2 A). This interference in the signal transduction cascade helps alter signaling dynamics in neural pathways. This mechanism influences the dynamics of central pain pathways and may alter the systemic consequences of the primary component's action.

Dosage and Administration Information

How to use Panadol Extra: Administration Guidelines

Panadol Extra, a fixed-dose combination of Paracetamol (500 mg) and Caffeine (65 mg), is designated for oral administration. The administration protocol is defined by specific dose, frequency, and duration limits.


Administration Scope Standard Guideline
Route of Administration Oral only. Film-coated tablets are swallowed whole with water. Effervescent forms must be dissolved in at least half a tumbler of water.
Standard Adult Dose Two tablets (1000 mg Paracetamol / 130 mg Caffeine) for individuals aged 16 years and over.
Dosing Frequency Doses may be repeated up to four times daily, maintaining a minimum interval of 4 hours between doses.
Maximum Daily Limit The total 24-hour intake must not exceed 8 tablets (4000 mg Paracetamol / 520 mg Caffeine).

Age-Group and Special Procedural Conditions

For adolescents aged 12 to 15 years, the unit dose is one tablet per administration, with a maximum of four tablets in 24 hours. Use is not recommended for children under 12 years. Administration is intended for short-term use only; prolonged or frequent use requires supervision from a healthcare professional.

To manage the total Paracetamol intake, instructions state that concurrent use with any other Paracetamol-containing product is prohibited. Furthermore, avoidance of excessive intake of dietary caffeine is advised due to the product's caffeine component. Dose reduction or interval prolongation is noted for patients with impaired renal or hepatic function, or those weighing less than 50 kg.

Connection to the overall use protocol

These instructions structure the use of the medicine as an intermittent, short-course protocol, defining the maximum dose and frequency to prevent exceeding established Paracetamol and Caffeine thresholds. The guidelines define usage within established parameters.

Recent Clinical Evidence

Recent Clinical Evidence

Efficacy of the Combination

Clinical research, including systematic reviews and randomized controlled trials (RCTs), has consistently evaluated the combination of paracetamol (acetaminophen) and caffeine for pain relief. The addition of a standard dose of caffeine (typically 100 mg to 130 mg) to paracetamol has been associated with a small but significant increase in analgesic efficacy across various acute pain states, including tension-type headache, dental pain, and post-partum pain.

Studies suggest that this combination may offer a modest increase in the proportion of participants achieving a good level of pain relief (defined as at least 50% of maximum pain relief) compared to paracetamol alone.


Speed of Absorption and Onset

Specific formulations of paracetamol/caffeine, such as those using Optizorb technology or sodium bicarbonate as an excipient, have been studied to assess their pharmacokinetic profiles. Bioequivalence studies have indicated that these formulations can lead to significantly faster absorption of paracetamol compared to conventional paracetamol tablets.

Faster absorption rates, as measured by the time to reach therapeutic plasma concentrations, are thought to contribute to a quicker onset of action. However, firm conclusions regarding the speed of pain relief compared with traditional over-the-counter analgesics remain under continued investigation.


Safety and Tolerability

Overall safety data, compiled from clinical trials and post-marketing surveillance, indicate that the combination of paracetamol and caffeine is generally well tolerated at recommended doses. Adverse events are typically mild and consistent with the known safety profiles of the individual components.

Commonly reported side effects related to the caffeine component may include nervousness, insomnia, or mild gastrointestinal disturbances, particularly when combined with dietary caffeine intake. The risk of paracetamol-related liver toxicity is primarily associated with overdosage and is not shown to be significantly increased by the presence of therapeutic doses of caffeine.

Frequently Asked Questions (FAQ)

Common questions about Panadol Extra (FAQ)

Q: What is Panadol Extra used for besides headaches?

Regulatory documents state that this medicine is indicated for the relief of various types of mild to moderate pain, in addition to headache. This includes pain associated with rheumatism, neuralgia, musculoskeletal disorders, toothache, sore throat, and period pain (dysmenorrhoea). Official product information also includes the relief of discomfort associated with feverishness and feverish colds.


Q: Can I take Panadol Extra if I have a history of stomach issues?

Official labeling notes that the Paracetamol component of the medicine is generally considered gentle on the stomach when used as directed, as it does not typically compromise the stomach’s protective lining, unlike some other pain relievers. However, mild gastrointestinal disturbances are listed as a possible side effect, often linked to the caffeine component. The need for use in individuals with pre-existing conditions requires consideration by a healthcare professional.


Q: Can Panadol Extra be taken on an empty stomach?

Official labeling indicates the active ingredient Paracetamol may be taken on an empty stomach. Unlike some other classes of pain relievers, it does not typically cause irritation to the stomach lining or require food to aid in its effective absorption.


Q: What are the most common side effects listed for Panadol Extra?

Adverse effects most commonly linked to the Caffeine component of the medicine include insomnia (difficulty sleeping), restlessness, anxiety, irritability, nervousness, headaches, gastrointestinal disturbances, and palpitations. These effects are noted to be potentially increased if combined with dietary caffeine intake.


Q: Can I take Panadol Extra if I have high blood pressure?

Due to the presence of the Central Nervous System (CNS) stimulant, Caffeine, official guidance indicates that the need for use in individuals being treated for high blood pressure requires consideration by a healthcare professional. This advice is related to the potential for caffeine to contribute to cardiac-related effects like palpitations.


Q: Is Panadol Extra habit-forming, according to official data?

The medicine is not typically classified as an addictive substance in regulatory documents. However, official regulatory documents do include a warning that prolonged, frequent use may lead to the development of Medication Overuse Headache (MOH).


Q: Can Panadol Extra cause problems sleeping?

Yes, regulatory documents explicitly list insomnia (sleeplessness) as a potential side effect. This is associated with the Caffeine component in the medicine, and the risk may increase if the medicine is taken close to bedtime or combined with other sources of caffeine.


Q: Why do some people use Panadol Extra for cold and flu symptoms?

The medicine’s regulatory indications include the symptomatic relief of discomfort associated with influenza, feverishness, and feverish colds. This reflects its dual-action benefit, providing both analgesic (pain-relieving) and antipyretic (fever-reducing) properties.


Q: Is it normal to feel a slight energy boost after taking Panadol Extra?

The medicine contains Caffeine, which is pharmacologically classified as a Central Nervous System (CNS) stimulant. This classification is consistent with the potential for feelings of increased alertness or restlessness in some individuals.


Q: Does taking Panadol Extra regularly make it less effective over time?

Official regulatory documents warn that the prolonged, frequent use of the medicine may be associated with the development of Medication Overuse Headache (MOH). This condition involves headaches becoming more frequent with continuous use.


Q: Are there known interactions between Panadol Extra and herbal supplements?

While specific herbal supplements are not universally listed in regulatory documents, official patient information generally advises individuals to tell their doctor or pharmacist about all medicines they are taking, including herbal supplements and other non-prescription products, for interaction consideration.


Q: What class of drug does Panadol Extra belong to?

Panadol Extra is officially classified as an Analgesic and Antipyretic Drug. It is a fixed-dose combination product, combining the pain-reliever Paracetamol with the Central Nervous System (CNS) stimulant Caffeine as an adjuvant.


Q: Can Panadol Extra be used to help with fever?

Yes, official regulatory documents state that the medicine is designated as an antipyretic (fever reducer). Its therapeutic indications include the relief of discomfort associated with feverishness and feverish colds.


Q: Is there a maximum number of days Panadol Extra should be taken consecutively?

Regulatory documents indicate that the medicine is for short-term use and generally specifies a limit of no more than 3 days without the involvement of a healthcare professional. Use exceeding this duration requires a healthcare review.


Q: Can Panadol Extra cause rebound headaches if used too frequently?

Regulatory safety warnings indicate that prolonged or frequent use of this type of analgesic may lead to a condition known as Medication Overuse Headache (MOH). This is the clinical term for the phenomenon users commonly refer to as a 'rebound headache.'

How should Panadol Extra be stored and disposed of?

How to Store and Dispose of Panadol Extra

Official regulatory guidelines strictly define the conditions under which Panadol Extra must be stored to maintain its labeled stability. The product is required to be stored at temperatures typically below 25 C or 30 C and should be kept in a cool, dry place and in its original package. If the medicine is supplied in a bottle, the cap must be closed tightly after each use. All packaging mandates that the medicine be stored out of the sight and reach of children.

Expired or unused Panadol Extra should not be disposed of via household waste or wastewater. Regulatory disposal instructions recommend returning the unused product to a pharmacist or utilizing an official drug take-back program. If household disposal is permitted by local guidelines, the medicine must be mixed with an undesirable substance, sealed in a container, and then placed in the trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Panadol Extra found in:

A-Z Index: